Medical News

RSS

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.

From Roche Sequencing and Life Science 25 Apr 2014

Iron consumption can increase risk for heart disease

A new study from the Indiana University School of Public Health-Bloomington has bolstered the link between red meat consumption and heart disease by finding a strong association between heme iron, found only in meat, and potentially deadly coronary heart disease.

24 Apr 2014

Increasing daily coffee consumption may lower type 2 diabetes risk

People who increased the amount of coffee they drank each day by more than one cup over a four-year period had a 11% lower risk for type 2 diabetes than those who made no changes to their coffee consumption, according to a new study led by Harvard School of Public Health (HSPH) researchers. In addition, the study found that those who decreased their coffee consumption by more than a cup per day increased their type 2 diabetes risk by 17%.

24 Apr 2014

Marijuana may cause heart complications in young people

Marijuana smoking may increase the risk of serious and even fatal heart problems among young or middle-aged users, according to a new French study.

24 Apr 2014

Biogen Idec's revenue increases 51% to $2.1 billion in first quarter 2014

Biogen Idec Inc. today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013.

23 Apr 2014

Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

The Instinct Endoscopic Hemoclip is now available to gastroenterologists in major global markets. The clip is used to stop gastrointestinal (GI) tract bleeding, which is a condition that can be challenging to treat because of the variations among bleeds.

From COOK MEDICAL INC. 23 Apr 2014

Tolero Pharmaceuticals' Alvocidib gets Orphan Drug Designation for acute myeloid leukemia treatment

Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).

23 Apr 2014

Early identification of heart disease a priority for schizophrenia patients

Early recognition and treatment of coronary artery disease must become a clinical priority for all adults with schizophrenia, say researchers who studied autopsy data for schizophrenia patients who died suddenly in hospital.

23 Apr 2014

Meta-analysis links signalling pathways to bipolar disorder

A meta-analysis of genome-wide association studies has identified six biological pathways that may be involved in the genetic predisposition to develop bipolar disorder.

23 Apr 2014

Political cartoon: 'Bill Of Health?'

Kaiser Health News provides a fresh take on health policy developments with "Bill Of Health?" by Mike Luckovich.

23 Apr 2014

Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

As a certified Health IT Quality Solution, Liaison Healthcare's EMR-Link solution has been recognized by Quest Diagnostics as meeting or exceeding advanced industry standards for health IT quality and for providing a streamlined, interoperable solution that enables secure clinical laboratory ordering and results reporting through Quest Diagnostics connectivity solutions.

From Quest Diagnostics 23 Apr 2014

Nearly 179 million cases of acute diarrhea occur each year in the U.S.

In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston concluded in a New England Journal of Medicine review article.

23 Apr 2014

WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

The Wireless-Life Sciences Alliance said today that its ninth annual Convergence Summit here next month will focus on achieving broader global adoption of technology-enabled health care at a time when the pace of innovation in connected health and personal health solutions is accelerating.

23 Apr 2014

NeoGenomics' revenue up 16.1% in first quarter 2014

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014.

23 Apr 2014

Engineering students create wearable treatment for infant jaundice

Around 60 percent of infants are born jaundiced and many spend their first days of life isolated underneath special lights that help them eliminate the excess bilirubin in their bloodstreams.

23 Apr 2014

Captisol-enabled Melphalan meets primary end points in phase 2 pivotal trial

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that its pivotal trial of Captisol-enabled (propylene glycol-free) Melphalan met its primary end points.

23 Apr 2014

Research grants could improve patients' recovery from athletic and nonathletic injuries

Two orthopedic organizations have presented Beaumont Health System with prestigious, competitive research grants that could improve patients' recovery from both athletic and nonathletic injuries.

23 Apr 2014

NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid Cleanser.

23 Apr 2014

Natus Medical reports revenue of $85.6 million in first quarter 2014

Natus Medical Incorporated today announced financial results for the three months ended March 31, 2014.

23 Apr 2014

Nuvo Research collaborates with Ferndale to develop 2 topical dermatology products

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. and a leading Contract Research Organization with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer technology.

23 Apr 2014

Medical News

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Iron consumption can increase risk for heart disease

Increasing daily coffee consumption may lower type 2 diabetes risk

Marijuana may cause heart complications in young people

Biogen Idec's revenue increases 51% to $2.1 billion in first quarter 2014

Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

Tolero Pharmaceuticals' Alvocidib gets Orphan Drug Designation for acute myeloid leukemia treatment

Early identification of heart disease a priority for schizophrenia patients

Meta-analysis links signalling pathways to bipolar disorder

Political cartoon: 'Bill Of Health?'

Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

Nearly 179 million cases of acute diarrhea occur each year in the U.S.

WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

NeoGenomics' revenue up 16.1% in first quarter 2014

Engineering students create wearable treatment for infant jaundice

Captisol-enabled Melphalan meets primary end points in phase 2 pivotal trial

Research grants could improve patients' recovery from athletic and nonathletic injuries

NovaBay introduces new eye care product to help patients with eyelids irritation

Natus Medical reports revenue of $85.6 million in first quarter 2014

Nuvo Research collaborates with Ferndale to develop 2 topical dermatology products

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News